Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Treasury Shares (2018 - 2025)

Historic Treasury Shares for STRATA Skin Sciences (SSKN) over the last 8 years, with Q3 2025 value amounting to $725976.0.

  • STRATA Skin Sciences' Treasury Shares changed N/A to $725976.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $725976.0, marking a year-over-year change of. This contributed to the annual value of $521726.0 for FY2024, which is 2293426.05% up from last year.
  • Latest data reveals that STRATA Skin Sciences reported Treasury Shares of $725976.0 as of Q3 2025.
  • In the past 5 years, STRATA Skin Sciences' Treasury Shares registered a high of $727726.0 during Q2 2025, and its lowest value of $851.0 during Q2 2024.
  • In the last 5 years, STRATA Skin Sciences' Treasury Shares had a median value of $89681.0 in 2022 and averaged $191095.0.
  • Per our database at Business Quant, STRATA Skin Sciences' Treasury Shares plummeted by 9786.54% in 2024 and then soared by 8541421.86% in 2025.
  • Quarter analysis of 5 years shows STRATA Skin Sciences' Treasury Shares stood at $90540.0 in 2021, then plummeted by 86.79% to $11960.0 in 2022, then plummeted by 81.06% to $2265.0 in 2023, then skyrocketed by 22934.26% to $521726.0 in 2024, then surged by 39.15% to $725976.0 in 2025.
  • Its Treasury Shares was $725976.0 in Q3 2025, compared to $727726.0 in Q2 2025 and $521726.0 in Q4 2024.